Keywords: fda, issues, public, health, advisory, pfizer, trovan

FDA issues public health advisory for Pfizer's Trovan

Article | 10 June 1999

Print This

Following post-marketing reports of hepatotoxic events leading to asmall number of liver transplants and deaths, the US Food and Drug ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in